SARS-CoV-2 Seroprevalence among the Health Care Staff of an Ophthalmological Reference Centre, a Cross Sectional Study

References

• Zheng J. SARS-CoV-2: an emerging coronavirus that causes a global threat. Int J Biol Sci. 2020;16(10):1678–1685. doi:10.7150/ijbs.45053.
   PubMed Web of Science ®Google Scholar
• Ludwig S, Zarbock A. Coronaviruses and SARS-CoV-2: a brief overview. Anesth Analg. 2020;131(1):93–96. doi:10.1213/ANE.0000000000004845.
   PubMed Web of Science ®Google Scholar
• Demartini K, Konzen VM, Siqueira MO, et al. Care for frontline health care workers in times of COVID-19. Rev Soc Bras Med Trop. 2020;53:e20200358. doi:10.1590/0037-8682-0358-2020.
   PubMed Web of Science ®Google Scholar
• Godderis L, Boone A, Bakusic J. COVID-19: a new work-related disease threatening healthcare workers. Occup Med (Lond). 2020;70(5):315–316. doi:10.1093/occmed/kqaa056.
   PubMed Web of Science ®Google Scholar
• Gomez-Ochoa SA, Franco OH, Rojas LZ, et al. COVID-19 in health-care workers: a living systematic review and meta-analysis of prevalence, risk factors, clinical characteristics, and outcomes. Am J Epidemiol. 2021;190(1):161–175. doi:10.1093/aje/kwaa191.
   PubMed Web of Science ®Google Scholar
• Gholami M, Fawad I, Shadan S, et al. COVID-19 and healthcare workers: a systematic review and meta-analysis. Int J Infect Dis. 2021;104:335–346. doi:10.1016/j.ijid.2021.01.013.
   PubMed Web of Science ®Google Scholar
• Antonio-Villa NE, Bello-Chavolla OY, Vargas-Vazquez A, Fermin-Martinez CA, Marquez-Salinas A, Bahena-Lopez JP. Health-care workers with COVID-19 living in Mexico City: clinical characterization and related outcomes. Clin Infect Dis. 2020;73(1):e191–e198.
   Google Scholar
• Wei JT, Liu ZD, Fan ZW, Zhao L, Cao WC. Epidemiology of and risk factors for COVID-19 infection among health care workers: a multi-centre comparative study. Int J Environ Res Public Health. 2020;17(19):7149. doi:10.3390/ijerph17197149.
   PubMed Web of Science ®Google Scholar
• Deeks JJ, Dinnes J, Takwoingi Y, et al. Antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database Syst Rev. 2020;6:CD013652.
   PubMed Web of Science ®Google Scholar
• Murchu O, Byrne P, Walsh KA, et al. Immune response following infection with SARS-CoV-2 and other coronaviruses: a rapid review. Rev Med Virol. 2020;31(2):e2162.
   PubMed Web of Science ®Google Scholar
• Long QX, Liu BZ, Deng HJ, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020;26(6):845–848. doi:10.1038/s41591-020-0897-1.
   PubMed Web of Science ®Google Scholar
• Jespersen S, Mikkelsen S, Greve T, et al. SARS-CoV-2 seroprevalence survey among 17,971 healthcare and administrative personnel at hospitals, pre-hospital services, and specialist practitioners in the central denmark region. Clin Infect Dis. 2020. doi:10.1093/cid/ciaa1471.
   Google Scholar
• Iversen K, Bundgaard H, Hasselbalch RB, et al. Risk of COVID-19 in health-care workers in denmark: an observational cohort study. Lancet Infect Dis. 2020;20(12):1401–1408. doi:10.1016/S1473-3099(20)30589-2.
   PubMed Web of Science ®Google Scholar
• Sotgiu G, Barassi A, Miozzo M, et al. SARS-CoV-2 specific serological pattern in healthcare workers of an Italian COVID-19 forefront hospital. BMC Pulm Med. 2020;20(1):203. doi:10.1186/s12890-020-01237-0.
   PubMed Web of Science ®Google Scholar
• Ledda C, Carrasi F, Longombardo MT, Paravizzini G, Rapisarda V. SARS-CoV-2 seroprevalence post-first wave among primary care physicians in Catania (Italy). Trop Med Infect Dis. 2021;6. doi:10.3390/tropicalmed6010021.
   Google Scholar
• Galan MI, Velasco M, Casas ML, et al. Hospital-Wide SARS-CoV-2 seroprevalence in health care workers in a Spanish teaching hospital. Enferm Infecc Microbiol Clin. 2020. doi:10.1016/j.eimc.2020.11.015.
   Google Scholar
• Garcia-Basteiro AL, Moncunill G, Tortajada M, et al. Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital. Nat Commun. 2020;11(1):3500. doi:10.1038/s41467-020-17318-x.
   PubMed Web of Science ®Google Scholar
• Martin CA, Patel P, Goss C, et al. Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff. J Public Health (Oxf). 2020. doi:10.1093/pubmed/fdaa199.
   Google Scholar
• Shields A, Faustini SE, Perez-Toledo M, et al. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study. Thorax. 2020;75(12):1089–1094. doi:10.1136/thoraxjnl-2020-215414.
   PubMed Web of Science ®Google Scholar
• Rudberg AS, Havervall S, Manberg A, et al. SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat Commun. 2020;11(1):5064. doi:10.1038/s41467-020-18848-0.
   PubMed Web of Science ®Google Scholar
• Mukwege D, Byabene AK, Akonkwa EM, et al. High SARS-CoV-2 seroprevalence in healthcare workers in bukavu, eastern democratic republic of congo. Am J Trop Med Hyg. 2021;104(4):1526–1530. doi:10.4269/ajtmh.20-1526.
   PubMed Web of Science ®Google Scholar
• Siva Ganesa Karthikeyan R, Rameshkumar G, Gowri PC, et al. Seroprevalence of SARS-CoV-2 specific IgG antibodies among eye care workers in South India Indian. J Med Microbiol. 2021. doi:10.1016/j.ijmmb.2021.06.014.
   Google Scholar
• Xu X, Sun J, Nie S, et al. Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China. Nat Med. 2020;26(8):1193–1195. doi:10.1038/s41591-020-0949-6.
   PubMed Web of Science ®Google Scholar
• Costa SF, Giavina-Bianchi P, Buss L, et al. SARS-CoV-2 seroprevalence and risk factors among oligo/asymptomatic healthcare workers(HCW): estimating the impact of community transmission. Clin Infect Dis. 2020. doi:10.1093/cid/ciaa1845.
   Google Scholar
• Rivett L, Sridhar S, Sparkes D, et al. Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission. Elife. 2020;9. doi:10.7554/eLife.58728.
   Google Scholar
• Grant MC, Geoghegan L, Arbyn M, et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systematic review and meta-analysis of 148 studies from 9 countries. PLoS One. 2020;15(6):e0234765. doi:10.1371/journal.pone.0234765.
   PubMed Web of Science ®Google Scholar
• Stringhini S, Wisniak A, Piumatti G, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020;396:313–319.
   PubMed Web of Science ®Google Scholar
• Liu Y, Yan LM, Wan L, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020;20(6):656–657. doi:10.1016/S1473-3099(20)30232-2.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062.
   PubMed Web of Science ®Google Scholar
• Weitz JS, Beckett SJ, Coenen AR, et al. Modeling shield immunity to reduce COVID-19 epidemic spread. Nat Med. 2020;26(6):849–854. doi:10.1038/s41591-020-0895-3.
   PubMed Web of Science ®Google Scholar
• Xie X, Zhong Z, Zhao W, Zheng C, Wang F, Chest LJ. CT for typical coronavirus disease 2019 (COVID-19) pneumonia: relationship to negative RT-PCR Testing. Radiology. 2020;296(2):E41–E45. doi:10.1148/radiol.2020200343.
   PubMed Web of Science ®Google Scholar